...round, announced this week.Co-founder, Chairman and CEO Brian McVeigh, a 25-year veteran of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK...
...partnering discussions with biopharmas as well. Its first external hire was Lauren Kaskiel, another former GSK...
...Rob Lin, NEA’s Ed Mathers, Takeda Ventures’ Victor Stone, Corporate Fuel Partners’ Russ Fein, former GSK...

...partnerships last year — Ideaya with GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) and...

...as global head of research and development. Hanon is a 20-year veteran of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK...

...By stephen hansen, associate editor Although GSK has declined to comment on reports that Elliott Management...
...to provide an opening for the activist investor to build a position in company.GlaxoSmithKline plc (LSE:GSK; NYSE:GSK...
...the matter, Elliott may push for GSK to reign in its R&D expenditure. Since 2018, GSK’s...

...By BioCentury Staff GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) said it is discontinuing treatment with ICOS agonist feladilimab (GSK3359609...
...carcinoma. The other study, INDUCE-4, was evaluating feladilimab vs. placebo in combination with pembrolizumab and chemotherapy. GSK...

...On Monday, the company announced a deal with GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) to test ZN-c3  in combination with GSK’s...

...to repurchase up to $1.2 billion in outstanding shares over the next 12-18 months.Royalty buys GSK's...
...a royalty interest in Cabometyx cabozantinib, which is also marketed as Cometriq, from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK...
...receive GSK's share of net ex-U.S. sales through the full term of the royalties and GSK's...

...the vaccine by age and sex in the Canadian context.” GSK to support Novavax vaccine manufacturingSeparately, GSK ...
...Inc. (NASDAQ:NVAX) to support manufacturing of up to 60 million doses of COVID-19 vaccine NVX-2373. GSK...
...tests. BC Staff COVID-19 Vaccine (AZD1222, ChAdOx1 nCoV-19) NVX-CoV2373 Covid 19 Vx, Comirnaty, Pfizer-BioNTech COVID-19 Vaccine (PF-07302048, BNT162, BNT162b2) AstraZeneca plc GlaxoSmithKline plc Novavax...

...NASDAQ:REGN).None of those EUAs cover low-risk patients. Lilly, Vir Biotechnology Inc. (NASDAQ:VIR), and Vir partner GlaxoSmithKline plc (LSE:GSK; NYSE:GSK...
...submissions for the combination with FDA and regulators in other countries.Lilly partnered with Vir and GSK...
...data from the Phase II/III COMET-ICE study. Sandi Wong bamlanivimab, LY-CoV555 (LY3819253) VIR-7831 (GSK4182136) Vir Biotechnology Inc. Eli Lilly and Co. GlaxoSmithKline plc AbCellera...

...delay opened the door for GlaxoSmithKline plc (LSE:GSK; NYSE:GSK...
...line in August. The FDA label for GSK’s...
...maraleucel, (JCAR017) bb21217 Ciltacabtagene autoleucel (JNJ-68284528, JNJ-4528, LCAR-B38M) bluebird bio Inc. GlaxoSmithKline plc Bristol...